Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Source:http://linkedlifedata.com/resource/pubmed/id/17551397

Download in:

View as

General Info

PMID
17551397